Treatment of Glycogen Storage Disease Type I with Hyperuricemia and Gout Attacks
Clinical scenario
Patients with Glycogen Storage Disease Type I may develop elevated uric acid levels (hyperuricemia) and, as a consequence, recurrent acute gout attacks. This combination requires specific management that addresses both the metabolic basis of hyperuricemia and the acute inflammatory episodes of gout.
Condition focus
The co-occurrence of hyperuricemia and gout attacks in GSD Type I reflects impaired uric acid handling associated with the underlying metabolic disorder. Preventing acute gouty episodes and reducing serum urate over time are central concerns in this patient population.
Treatment approach — partial overview
Management in this setting involves dietary measures alongside urate-lowering pharmacotherapy; a separate pharmacological strategy addresses acute gouty episodes. The complete structured regimen — including sequencing and all options — is available via the link below.
References
DOI: 10.1038/gim.2014.128
- For those with a tendency toward gout attacks, a low-purine diet is prescribed in addition to allopurinol.
- Use of agents, such as Allopurinol and Febuxostat, have been used to lower uric acid levels.
- Colchicine has been used with success in the acute setting of gouty attacks.
View source ↗